After 6 months of semaglutide use, 51% of patients achieved a BMI reduction 5%, and 22% achieved a BMI reduction 10%
BMC Gastroenterology, 17(1), Article 96
Backed by robust clinical trials and cutting-edge research and data science, these therapies are changing the way we approach weight loss and diabetes management
Many patients and their healthcare providers would prefer to avoid injections if possible due to the challenges associated with giving/receiving an injection, the complex storage conditions requiring freezing/refrigeration, and the short expiration dating per USP guidelines
FeNO is a well-recognized marker of T2 inflammation, being elevated in asthma and dramatically lowered by targeted T2/IL-4 receptor antibodies (11, 12)
Safety Considerations and Who Should Start GLP-1 for PCOS GLP-1 agonists are not suitable for everyone with PCOS